Merck: There is still a huge data gap in the single-dose plan of the HPV vaccine, Wantai Biotech’s net profit surged in the first quarter in response to the sharp drop in the stock price_WHO_Immunization_Wantai
Original title: Merck: There is still a huge data gap in the single-dose plan of the HPV vaccine, Wantai Bio’s first-quarter net profit surged in response to the sharp drop in the stock price On April 17, the Red Star Capital Bureau reported that a single-dose HPV vaccine proposed by the WHO can provide reliable […]
Borui Pharmaceuticals has been approved to imitate the new crown oral drug, but the market is limited or difficult to do – yqqlm
Original title: Borui Pharmaceutical has been approved to imitate the new crown oral drug, but the market is limited or difficult to do Borui Medicine opened the daily limit today (January 21) because it was approved to imitate Merck’s new crown oral drug. On January 20, MPP, a drug patent pool organization, announced an agreement […]
U.S. FDA approves Pfizer edible coronavirus treatment… Started review of emergency use approval in Korea: Dong-A Science
Pfizer paxrovid oral treatment pills. Eun-Joo Park, Yonhap News An edible novel coronavirus infection (COVID-19) treatment developed by US pharmaceutical company Pfizer has been approved for use by the US Food and Drug Administration (FDA). This is the first pill treatment that can be taken at home rather than by injection. In Korea, the Ministry […]
U.S. FDA approves Pfizer edible coronavirus treatment… Started review of emergency use approval in Korea: Dong-A Science
Pfizer paxrovid oral treatment pills. Eun-Joo Park, Yonhap News An edible novel coronavirus infection (COVID-19) treatment developed by US pharmaceutical company Pfizer has been approved for use by the US Food and Drug Administration (FDA). This is the first pill treatment that can be taken at home rather than by injection. In Korea, the Ministry […]
The world’s first oral treatment for COVID-19 is imminent… The game changer is ‘Well’
▲Merck (MSD), an oral treatment for the novel coronavirus infection (COVID-19) of the United States, Molnupiravir (Kenilworth AP = Yonhap News) As global pharmaceutical company Merck (MSD) announced the interim results of the phase 3 clinical trial for the novel coronavirus infection (COVID-19) oral treatment, expectations for a gradual recovery of daily life (with Corona) […]